Home » Stocks » KTTA

Pasithea Therapeutics Corp. (KTTA)

Pasithea Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Pasithea Therapeutics Corp. has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC

About KTTA

Pasithea Therapeutics is a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. As of March 26, 2021, the Company had not commenced core operations. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses. Our biotech operations will focus on developing drugs that target the pathophysiology underlying such disorders rather than symptomatic treatments, with the goal of developing n... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Pending
CEO
Dr. Tiago Reis Marques
Employees
3
Stock Exchange
NASDAQ
Ticker Symbol
KTTA
Full Company Profile